Abstract:Background and Aims Dysregulation of alternative splicing is implicated in many human diseases and understanding the genetic variation underlying transcript splicing is essential to dissect the molecular mechanisms of cancers. We aimed to provide a comprehensive functional dissection of splicing quantitative trait loci (sQTLs) in cancer and focus on elucidating its distinct role in colorectal cancer (CRC) mechanisms. Methods Firstly, we performed a comprehensive sQTL analysis to identify genetic variants that control mRNA splicing across 33 cancer types from TCGA and independently validated in our 154 CRC tissues. Then, large-scale, multicenter, multiethnic case-control studies (34,585 cases and 76,023 controls) were conducted to examine the association of these sQTLs with CRC risk. A series of biological experiments in vitro and in vivo were performed to investigate the potential mechanisms of the candidate sQTLs and target genes. Results The molecular characterization of sQTL revealed its distinct role in cancer susceptibility. Tumor-specific sQTL further showed better response to cancer development. Besides, functionally informed polygenetic risk score highlighted the potentiality of sQTLs in the CRC prediction. Complemented by large-scale population studies, we identified that the risk allele (T) of a multi-ancestry-associated sQTL rs61746794 significantly increased the risk of CRC in Chinese populations (OR=1.20, 95% CI=1.12-1.29, P =8.82×10 -7 ) and European populations (OR=1.11, 95% CI=1.07-1.16, P =1.13×10 -7 ). rs61746794-T facilitated PRMT7 exon 16 splicing mediated by the RBP PRPF8, thus increasing the level of canonical PRMT7 isoform ( PRMT7 -V2). Overexpression of PRMT7 -V2 significantly enhanced the growth of CRC cells and xenograft tumors, compared with PRMT7 -V1. Mechanistically, PRMT7-V2 functions as an epigenetic writer that catalyzes the arginine methylation of H4R3 and H3R2, subsequently regulating diverse biological processes, including YAP, AKT, and KRAS pathway. A selective PRMT7 inhibitor, SGC3027, exhibited antitumor effects on human CRC cells. Conclusions Our study provide an informative sQTLs resource and insights into the regulatory mechanisms linking splicing variants to cancer risk, serving as biomarkers and therapeutic targets.

Genome-wide profiling reveals cancer-related genes with switched alternative polyadenylation sites in colorectal cancer.

Genome-wide Profiling of Polyadenylation Sites Reveals a Link Between Selective Polyadenylation and Cancer Metastasis

Post-Transcriptional Dysregulation of microRNA and Alternative Polyadenylation in Colorectal Cancer

Large-scale alternative polyadenylation-wide association studies to identify putative cancer susceptibility genes

Alternative Polyadenylation Associated with Prognosis and Therapy in Colorectal Cancer.

Whole Exome Sequencing Of Ulcerative Colitis-Associated Colorectal Cancer Based On Novel Somatic Mutations Identified In Chinese Patients

Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci

Large-scale alternative polyadenylation (APA)-wide association studies to identify putative susceptibility genes in human common cancers

Differential Genome-Wide Profiling of Tandem 3 ' Utrs among Human Breast Cancer and Normal Cells by High-Throughput Sequencing

Data from Characterization of Immune-Related Alternative Polyadenylation Events in Cancer Immunotherapy

Whole Exome Sequencing of Ulcerative Colitis–associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients

Comprehensive Analysis of Alternative Polyadenylation Events Associated with the Tumor Immune Microenvironment in Colon Adenocarcinoma

Characterization of immune-related alternative polyadenylation events in cancer immunotherapy

Alternative polyadenylation shapes the molecular and clinical features of lung adenocarcinoma

Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer

A distinct class of pan-cancer susceptibility genes revealed by an alternative polyadenylation transcriptome-wide association study

Alternative Polyadenylation Modification Patterns Reveal Essential Posttranscription Regulatory Mechanisms of Tumorigenesis in Multiple Tumor Types.

Differential Genome-Wide Profiling of Alternative Polyadenylation Sites in Nasopharyngeal Carcinoma by High-Throughput Sequencing

Alternative Polyadenylation: Methods, Mechanism, Function, and Role in Cancer.

Genetic control of alternative splicing and its distinct role in colorectal cancer mechanisms

Alternative Polyadenylation in Glioblastoma Multiforme and Changes in Predicted RNA Binding Protein Profiles.